Quarterly report pursuant to Section 13 or 15(d)

REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details)

v3.23.1
REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues $ 12,165 $ 20,796
Qbrexza    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 4,094 7,376
Accutane    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 4,648 4,907
Amzeeq    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 1,193 3,466
Targadox    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 793 2,634
Ximino    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 612 967
Exelderm    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 511 704
Zilxi    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues $ 314 741
Other branded revenue    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues   $ 1